Fig. 1From: Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trialTreatment exposure by diabetes status. Time on study drug calculated from the date of the first study drug administration to the date of the last study drug injection plus 1Â day. FCM ferric carboxymaltose; SD standard deviationBack to article page